Insider · CIK 0001434718

Oliviero James F III

CIK 0001434718 Name as filed on the most recent filing

Filed as Oliviero James F III (47)

62 transaction lines · from 47 filings · filed 2009-05-22 to 2025-04-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

62 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-04-02 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 60,964, disposed Open Form 4 filing 0001104659-25-031813
2025-02-10 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 32,543, disposed Open Form 4 filing 0001104659-25-011656
2025-02-07 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 31,485, disposed Open Form 4 filing 0001104659-25-011656
2024-12-19 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 744,377, disposed Open Form 4 filing 0001104659-24-130963
2024-12-18 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 2,330,386, disposed Open Form 4 filing 0001104659-24-130963
2024-06-26 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 50,451, disposed Open Form 4 filing 0001104659-24-076442
2024-02-28 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 12,142, disposed Open Form 4 filing 0001104659-24-030149
2024-02-01 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 23,919, disposed Open Form 4 filing 0001104659-24-010265
2023-03-02 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 27,415, disposed Open Form 4 filing 0001104659-23-028603
2023-02-27 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 25,798, disposed Open Form 4 filing 0001104659-23-028603
2023-02-01 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 48,945, disposed Open Form 4 filing 0001104659-23-010771
2023-01-10 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 25,761, disposed Open Form 4 filing 0001104659-23-003529
2022-06-23 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 16,650, disposed Open Form 4 filing 0001104659-22-076976
2022-06-22 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 13,080, disposed Open Form 4 filing 0001104659-22-076976
2022-06-21 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 22,890, disposed Open Form 4 filing 0001104659-22-076976
2022-06-17 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 248,520, disposed Open Form 4 filing 0001104659-22-076976
2022-04-13 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 32,100, disposed Open Form 4 filing 0001104659-22-049156
2022-04-05 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 24,833, disposed Open Form 4 filing 0001104659-22-049156
2022-04-04 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 154,572, disposed Open Form 4 filing 0001104659-22-049156
2021-02-05 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 166,745, disposed Open Form 4 filing 0001104659-21-013180
2021-02-04 S, Open-market sale Checkpoint Therapeutics, Inc.CKPT 245,525, disposed Open Form 4 filing 0001104659-21-013180
2015-07-06 S, Open-market sale Keryx Biopharmaceuticals IncKERX 18,672, disposed Open Form 4 filing 0000899243-15-000941
2015-04-06 S, Open-market sale Keryx Biopharmaceuticals IncKERX 21,935, disposed Open Form 4 filing 0001209191-15-033264
2015-01-05 S, Open-market sale Keryx Biopharmaceuticals IncKERX 77,279, disposed Open Form 4 filing 0001209191-15-002621
2014-12-10 S, Open-market sale Keryx Biopharmaceuticals IncKERX 392,250, disposed Open Form 4 filing 0001209191-14-075121
2014-10-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 43,481, disposed Open Form 4 filing 0001209191-14-062374
2014-09-08 S, Open-market sale Keryx Biopharmaceuticals IncKERX 2,290,484, disposed Open Form 4 filing 0001209191-14-057381
2014-07-07 S, Open-market sale Keryx Biopharmaceuticals IncKERX 32,351, disposed Open Form 4 filing 0001209191-14-046590
2014-04-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 34,352, disposed Open Form 4 filing 0001209191-14-026240
2014-03-21 S, Open-market sale Keryx Biopharmaceuticals IncKERX 203,139, disposed Open Form 4 filing 0001209191-14-022560
2014-03-20 S, Open-market sale Keryx Biopharmaceuticals IncKERX 1,880,000, disposed Open Form 4 filing 0001209191-14-022560
2014-03-19 S, Open-market sale Keryx Biopharmaceuticals IncKERX 2,346,014, disposed Open Form 4 filing 0001209191-14-022560
2014-01-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 79,304, disposed Open Form 4 filing 0001181431-14-001475
2013-12-30 S, Open-market sale Keryx Biopharmaceuticals IncKERX 2 lines 1,003,890, disposed Open Form 4 filing 0001181431-13-065072
2013-12-27 S, Open-market sale Keryx Biopharmaceuticals IncKERX 380,400, disposed Open Form 4 filing 0001181431-13-065072
2013-10-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 15,119, disposed Open Form 4 filing 0001181431-13-052946
2013-07-05 S, Open-market sale Keryx Biopharmaceuticals IncKERX 11,432, disposed Open Form 4 filing 0001181431-13-039327
2013-05-13 S, Open-market sale Keryx Biopharmaceuticals IncKERX 244,887, disposed Open Form 4 filing 0001181431-13-027758
2013-04-05 S, Open-market sale Keryx Biopharmaceuticals IncKERX 10,284, disposed Open Form 4 filing 0001144204-13-020683
2013-01-04 S, Open-market sale Keryx Biopharmaceuticals IncKERX 29,754, disposed Open Form 4 filing 0001144204-13-000856
2012-10-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 13,527, disposed Open Form 4 filing 0001144204-12-055031
2012-07-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 9,072, disposed Open Form 4 filing 0001144204-12-038525
2012-04-05 S, Open-market sale Keryx Biopharmaceuticals IncKERX 8,738, disposed Open Form 4 filing 0001144204-12-020459
2012-01-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 18,874, disposed Open Form 4 filing 0001144204-12-000306
2011-10-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 17,192, disposed Open Form 4 filing 0001144204-11-056628
2011-07-05 S, Open-market sale Keryx Biopharmaceuticals IncKERX 22,133, disposed Open Form 4 filing 0001144204-11-039658
2011-06-06 S, Open-market sale Keryx Biopharmaceuticals IncKERX 235,683, disposed Open Form 4 filing 0001144204-11-034757
2011-04-05 S, Open-market sale Keryx Biopharmaceuticals IncKERX 22,899, disposed Open Form 4 filing 0001144204-11-020841
2011-01-03 S, Open-market sale Keryx Biopharmaceuticals IncKERX 65,679, disposed Open Form 4 filing 0001144204-11-000205

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 60
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Oliviero James F III, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001434718

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.